Cargando…
Serum Exosomal miR-941 as a promising Oncogenic Biomarker for Laryngeal Squamous Cell Carcinoma
At present, no blood-based biomarkers have been used in clinical practice for laryngeal squamous cell carcinoma (LSCC). Increasing evidence suggests that circulating exosomal microRNAs (miRNAs) may serve as potential diagnostic biomarkers for various cancers. This study aims to identify and evaluate...
Autores principales: | Zhao, Qinli, Zheng, Xiwang, Guo, Huina, Xue, Xuting, Zhang, Yuliang, Niu, Min, Cui, Jiajia, Liu, Hongliang, Luo, Hongjie, Yang, Dongli, Shi, Yong, Huangfu, Hui, Wen, Shuxin, Wu, Yongyan, Gao, Wei, Wang, Binquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391210/ https://www.ncbi.nlm.nih.gov/pubmed/32742479 http://dx.doi.org/10.7150/jca.45394 |
Ejemplares similares
-
Alterations of bacterial communities of vocal cord mucous membrane increases the risk for glottic laryngeal squamous cell carcinoma
por: Dong, Zhen, et al.
Publicado: (2021) -
Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1
por: Gao, Wei, et al.
Publicado: (2019) -
Analysis of gene expression profiling variations induced by hsa-miR-145-5p-overexpression in laryngeal squamous cell carcinoma cell line Tu-177
por: Ding, Yongxia, et al.
Publicado: (2017) -
Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1–AKT axis-mediated glycolysis
por: Gao, Wei, et al.
Publicado: (2020) -
Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma
por: Cui, Jiajia, et al.
Publicado: (2019)